MedPath

ong term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score

Recruiting
Conditions
Pneumonia in COVID infectionMulti organ failure,sepsis
Registration Number
DRKS00021537
Lead Sponsor
Klinikum Stuttgart
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

All patients with V.a. COVID-19. Period from March 2020 to probably June 2021. Studies are included regardless of gender or age (minors excluded). So there is no exclusion from pregnant patients if there is an emergency indication.

Exclusion Criteria

underage patients

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity levels of COVID pneumonia and mortality factor in computer tomography in the acute phase of the disease.<br>Chronic lung damage according to the criteria of computer tomography in aftercare (at least 4 weeks after discharge).
Secondary Outcome Measures
NameTimeMethod
In the acute phase of pneumonia: symmetry of the attack in both halves of the lungs. Transition from interstitial to alveolar involvement in computed tomography. Correlation between course in the lungs and laboratory parameters.<br><br>In aftercare (at least 4 weeks after discharge): change in pulmonary function (pulmonary function test).
© Copyright 2025. All Rights Reserved by MedPath